Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference
November 28 2016 - 06:00AM
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that
Jason Shandell, President will be presenting at the 2016 Piper
Jaffray Healthcare Conference on Wednesday, November 30, 2016 at
11:00 a.m. Eastern Time in New York, NY.
This presentation will be made available with a
live webcast and may be accessed by visiting Amphastar
Pharmaceuticals' website at http://ir.amphastar.com/events.cfm.
This webcast will be available for 90 days following the
presentation.
About Amphastar:
Amphastar is a specialty pharmaceutical company
that focuses primarily on developing, manufacturing, marketing, and
selling technically-challenging generic and proprietary injectable,
inhalation, and intranasal products. Additionally, the Company
sells insulin active pharmaceutical ingredient products. Most of
the Company’s finished products are used in hospital or urgent care
clinical settings and are primarily contracted and distributed
through group purchasing organizations and drug wholesalers. More
information is available at the Company’s website at
www.amphastar.com.
The Amphastar Pharmaceuticals logo and other
trademarks or service marks of Amphastar
Pharmaceuticals, Inc., including, but not limited to
Primatene®, Amphadase® and Cortrosyn®, are the property of
Amphastar Pharmaceuticals, Inc.
Forward-Looking Statement:
All statements in this press release referenced
above that are not historical are forward-looking statements,
including, among other things, statements relating to the Company’s
expectations regarding future financial performance, sales and
marketing of its products, market size and growth, the timing of
FDA filings or approvals, acquisitions and other matters related to
its pipeline of product candidates, its share buyback program and
other future events. These statements are not historical
facts but rather are based on Amphastar’s historical performance
and its current expectations, estimates, and projections regarding
Amphastar’s business, operations and other similar or related
factors. Words such as “may,” “might,” “will,” “could,” “would,”
“should,” “anticipate,” “predict,” “potential,” “continue,”
“expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and
other similar or related expressions are used to identify these
forward-looking statements, although not all forward-looking
statements contain these words. You should not place undue reliance
on forward-looking statements because they involve known and
unknown risks, uncertainties, and assumptions that are difficult or
impossible to predict and, in some cases, beyond Amphastar’s
control. Actual results may differ materially from those in the
forward-looking statements as a result of a number of factors,
including those described in Amphastar’s filings with the
Securities and Exchange Commission. You can locate these reports
through the Company’s website at http://ir.amphastar.com and on the
SEC’s website at www.sec.gov. Amphastar undertakes no obligation to
revise or update information in this press release or the
conference call referenced above to reflect events or circumstances
in the future, even if new information becomes available or if
subsequent events cause the Company’s expectations to change.
Contact:
William J. Peters
Chief Financial Officer
(909) 476-3416
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Mar 2023 to Mar 2024